Antimicrobial

Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™

Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety…

2 months ago

Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™

Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety…

2 months ago

EVŌQ Nano Secures Strategic Investment From Global Business Leader & Philanthropist Tony Robbins to Advance Next-Generation Antimicrobial Nanoparticle Technology

SALT LAKE CITY, Jan. 30, 2025 /PRNewswire/ -- EVŌQ Nano, a nanoscience company that engineers novel nanoparticles for the life,…

2 months ago

Qualigen to participate in next funding round for NanoSynex

Market size expected to reach $4.7 billion in 2027 CARLSBAD, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc.…

3 months ago

Recce Pharmaceuticals Doses All Patients in Phase II Trial of RECCE® 327 Topical Gel in Acute Bacterial Skin and Skin Structure Infections

Preliminary data indicates patients experienced either a complete cure or significant improvement in infection symptoms following treatment with R327GFull data…

3 months ago

Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology

Thursday, January 23rd, 2025 at 4:15pm Eastern TimeWINNIPEG, Manitoba, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE;…

3 months ago

Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments

-- Brendan Teehan named Chief Commercial Officer and Krys Corbett named Chief Business Officer -- -- Key additions expected to…

3 months ago

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act’s Medicare Negotiation Program

LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business,…

3 months ago

BioWorld by Clarivate Releases Comprehensive 2024 Year in Review

Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld™…

3 months ago

Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization

Company also reports preliminary unaudited 2024 revenue of $701.0 millionPARSIPPANY, N.J., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc.…

3 months ago